Detalhe da pesquisa
1.
PSMA ADC monotherapy in patients with progressive metastatic castration-resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open-label single-arm phase 2 study.
Prostate
; 80(1): 99-108, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31742767
2.
An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma.
Oncologist
; 24(6): 747-e218, 2019 06.
Artigo
Inglês
| MEDLINE | ID: mdl-30598500
3.
Randomized Phase II Trial of Seribantumab in Combination with Erlotinib in Patients with EGFR Wild-Type Non-Small Cell Lung Cancer.
Oncologist
; 24(8): 1095-1102, 2019 08.
Artigo
Inglês
| MEDLINE | ID: mdl-30975923
4.
A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
Am J Hematol
; 92(3): 286-291, 2017 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28052413
5.
Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.
Cancer
; 122(15): 2418-25, 2016 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27176138
6.
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracycline and cyclophosphamide regimens in patients with cancer: a randomised, active-controlled, double-blind, phase 3 trial.
Lancet Oncol
; 16(9): 1071-1078, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26272768
7.
Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in patients with cancer: two randomised, active-controlled, double-blind, phase 3 trials.
Lancet Oncol
; 16(9): 1079-1089, 2015 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-26272769
8.
Phase 1/2 study of KRN330, a fully human anti-A33 monoclonal antibody, plus irinotecan as second-line treatment for patients with metastatic colorectal cancer.
Invest New Drugs
; 32(4): 682-90, 2014 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-24691674
9.
Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial.
Lancet Oncol
; 14(1): 72-80, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23246022
10.
Filanesib plus bortezomib and dexamethasone in relapsed/refractory t(11;14) and 1q21 gain multiple myeloma.
Cancer Med
; 11(2): 358-370, 2022 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34921527
11.
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort.
Cancer
; 117(22): 5067-73, 2011 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-21681734
12.
Adjuvant docetaxel for node-positive breast cancer.
N Engl J Med
; 352(22): 2302-13, 2005 Jun 02.
Artigo
Inglês
| MEDLINE | ID: mdl-15930421
13.
A Phase 2 Randomized, Double-Blind, Multicenter Trial of Imexon Plus Gemcitabine Versus Gemcitabine Plus Placebo in Patients With Metastatic Chemotherapy-naïve Pancreatic Adenocarcinoma.
Am J Clin Oncol
; 41(3): 230-235, 2018 03.
Artigo
Inglês
| MEDLINE | ID: mdl-26709865
14.
nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC.
Front Oncol
; 8: 262, 2018.
Artigo
Inglês
| MEDLINE | ID: mdl-30087851
15.
Randomized phase I trial of recombinant human keratinocyte growth factor plus chemotherapy: potential role as mucosal protectant.
J Clin Oncol
; 21(8): 1452-8, 2003 Apr 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12697866
16.
Phase I and pharmacokinetic study of triapine, a potent ribonucleotide reductase inhibitor, administered daily for five days in patients with advanced solid tumors.
Clin Cancer Res
; 9(11): 4092-100, 2003 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-14519631
17.
A phase I/II study of LY900003, an antisense inhibitor of protein kinase C-alpha, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer.
Clin Cancer Res
; 10(18 Pt 1): 6086-93, 2004 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-15447994
18.
An educational program to increase cervical and breast cancer screening in Hispanic women: a Southwest Oncology Group study.
Cancer Nurs
; 28(1): 47-53, 2005.
Artigo
Inglês
| MEDLINE | ID: mdl-15681982
19.
PRONOUNCE: randomized, open-label, phase III study of first-line pemetrexed + carboplatin followed by maintenance pemetrexed versus paclitaxel + carboplatin + bevacizumab followed by maintenance bevacizumab in patients ith advanced nonsquamous non-small-cell lung cancer.
J Thorac Oncol
; 10(1): 134-42, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25371077
20.
Phase I and pharmacokinetic study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule.
Cancer Chemother Pharmacol
; 50(3): 223-9, 2002 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-12203104